Trial intelligence / Profile preview

Dexmedetomidine and Magnesium Sulfate in Preventing Postoperative JET After Pediatric Cardiac Surgery

NCT05554848Phase 4Completed

Sponsor
Kasr Al Ainy Hospital
Start
Sep 2022
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine, magnesium sulfate in Junctional Ectopic Tachycardia (JET), sponsored by Kasr Al Ainy Hospital. Started Sep 2022; status: completed.

02

Drugs

dexmedetomidinemagnesium sulfate
03

Conditions

Junctional Ectopic Tachycardia (JET)

Beyond the preview

Go deeper on NCT05554848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05554848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call